Key result
Endothelin-1 exerts a negative inotropic effect in mouse cardiomyocytes by reducing myofilament Ca2+ sensitivity and increasing Ca2+ extrusion via Na+-Ca2+ exchange.
Highlights novel evidence that ET-1 exerts a negative inotropic effect in mouse cardiomyocytes through Na+-Ca2+ exchange, contrasting with its positive inotropic effects in other species.
Endothelin-1 (ET-1) is a peptide hormone produced within the myocardium which may modulate myocardial contractility in a paracrine-autocrine fashion. In the majority of species, ET-1 has a direct positive inotropic effect on the myocardium that involves both increased myofilament Ca(2+) sensitivity and increased Ca(2+) transients. Ca(2+) entry through reverse-mode Na(+)-Ca(2+) exchange, involving both indirect effects via elevation of intracellular [Na(+)] and direct activation of the Na(+)-Ca(2+) exchanger, have been suggested to contribute to the increase in Ca(2+) transients. Conversely, mouse cardiomyocytes show an exclusively negative inotropic response to ET-1. Here, Nishimaru and colleagues present novel evidence that the negative inotropic effect of ET-1 in mouse cardiomyocytes involves both a reduction in myofilament Ca(2+) sensitivity and increased Ca(2+) extrusion, via Na(+)-Ca(2+) exchange. Data obtained using the selective Na(+)-Ca(2+) exchange blocker, SEA0400, suggest that a re-assessment of the role of the exchanger in Ca(2+)-handling by mouse cardiomyocytes may be necessary.
No takes yet. Share an insight, caveat, or question.
Andrew F. James (2007) reported an editorial. Endothelin-1 (ET-1) was evaluated on Myocardial contractility and Ca2+ handling. Endothelin-1 exerts a negative inotropic effect in mouse cardiomyocytes by reducing myofilament Ca2+ sensitivity and increasing Ca2+ extrusion via Na+-Ca2+ exchange.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: